Evidence map›Paper›PMID 36851334›Full record

ArticleVaccines2023

Immunogenicity and Safety of a Combined Intramuscular/Intranasal Recombinant Spike Protein COVID-19 Vaccine (RCP) in Healthy Adults Aged 18 to 55 Years Old: A Randomized, Double-Blind, Placebo-Controlled, Phase I Trial.

Masoud Solaymani Dodaran, Seyed Reza Banihashemi, Ali Es-Haghi, Mohammad Hossein Fallah Mehrabadi, Mojtaba Nofeli, Ali Rezaei Mokarram, Ladan Mokhberalsafa, Fariba Sadeghi, Alireza Ranjbar, Akram Ansarifar and 16 more

Open access · goldAbstract read
In one paragraph

Article in Vaccines, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed, 1 pooled it
2.7field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 1 synthesis or guideline pooled it, 14 citations in OpenAlex.

  1. Mucosal immunity and vaccine development.Signal transduction and targeted therapy · 2026
    Pooled it
  2. Trial
  3. Review
  4. Molecular mechanisms of SARS-CoV-2 entry: implications for biomedical strategies.Microbiology and molecular biology reviews : MMBR · 2025
    Review
  5. Review
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

26 authors at 5 institutions in 2 countries.

Masoud Solaymani DodaranClinical Trial Center, Iran University of Medical Science, Tehran 1449614535, Iran.
Seyed Reza BanihashemiDepartment of Immunology, Razi Vaccine and Serum Research Institute, Agricultural Research, Education and Extension Organization (AREEO), Karaj P.O. Box 31975/148, Iran.
Ali Es-HaghiDepartment of Physico Chemistry, Razi Vaccine and Serum Research Institute, Agricultural Research, Education and Extension Organization (AREEO), Karaj P.O. Box 31975/148, Iran.ORCID 0000-0001-6533-3656
Mohammad Hossein Fallah MehrabadiDepartment of Epidemiology, Razi Vaccine and Serum Research Institute, Agricultural Research, Education and Extension Organization (AREEO), Karaj P.O. Box 31975/148, Iran.
Mojtaba NofeliDepartment of Research and Development, Razi Vaccine and Serum Research Institute, Agricultural Research, Education and Extension Organization (AREEO), Karaj P.O. Box 31975/148, Iran.
Ali Rezaei MokarramDepartment of QA, Razi Vaccine and Serum Research Institute, Agricultural Research, Education and Extension Organization (AREEO), Karaj P.O. Box 31975/148, Iran.
Ladan MokhberalsafaDepartment of Health, Razi Vaccine and Serum Research Institute, Agricultural Research, Education and Extension Organization, Karaj P.O. Box 31975/148, Iran.ORCID 0000-0002-9437-4067
Fariba SadeghiDepartment of Health, Razi Vaccine and Serum Research Institute, Agricultural Research, Education and Extension Organization, Karaj P.O. Box 31975/148, Iran.
Alireza RanjbarInstitute of Interventional Allergology and Immunology, Bonn/Cologne, 53115 Bonn, Germany.
Akram AnsarifarSchool of Public Health, Iran University of Medical Science, Tehran 1449614535, Iran.
Arash MohazzabSchool of Public Health, Iran University of Medical Science, Tehran 1449614535, Iran.
Seyed Amin SetarehdanMinimally Invasive Surgery Research Center, Hazrat-e-Rasool Hospital, Iran University of Medical Science, Tehran 1445613113, Iran.ORCID 0000-0003-0596-3175
Fahimeh Bagheri AmiriDepartment of Epidemiology and Biostatistics, Research Centre for Emerging and Reemerging Infectious Diseases, Pasteur Institute of Iran, Tehran 1316943551, Iran.
Vahideh MohseniSchool of Public Health, Iran University of Medical Science, Tehran 1449614535, Iran.
Monireh HajimoradiDepartment of Immunology, Razi Vaccine and Serum Research Institute, Agricultural Research, Education and Extension Organization (AREEO), Karaj P.O. Box 31975/148, Iran.
Neda GhahremanzadehSchool of Public Health, Iran University of Medical Science, Tehran 1449614535, Iran.
Seyed Hossein RazzazDepartment of Immunology, Razi Vaccine and Serum Research Institute, Agricultural Research, Education and Extension Organization (AREEO), Karaj P.O. Box 31975/148, Iran.
Safdar MasoomiDepartment of Biostatistics, Faculty of Medical Sciences, Tarbiat Modares University, Tehran P.O. Box 14115/111, Iran.
Maryam TaghdiriDepartment of Immunology, Razi Vaccine and Serum Research Institute, Agricultural Research, Education and Extension Organization (AREEO), Karaj P.O. Box 31975/148, Iran.
Mohsen BagheriDepartment of Physico Chemistry, Razi Vaccine and Serum Research Institute, Agricultural Research, Education and Extension Organization (AREEO), Karaj P.O. Box 31975/148, Iran.
Mohsen LoftiDepartment of QA, Razi Vaccine and Serum Research Institute, Agricultural Research, Education and Extension Organization (AREEO), Karaj P.O. Box 31975/148, Iran.
Akbar KhorasaniDepartment of Research and Development, Razi Vaccine and Serum Research Institute, Agricultural Research, Education and Extension Organization (AREEO), Karaj P.O. Box 31975/148, Iran.
Masoud GhaderDepartment of Physico Chemistry, Razi Vaccine and Serum Research Institute, Agricultural Research, Education and Extension Organization (AREEO), Karaj P.O. Box 31975/148, Iran.
Shiva SafariSchool of Public Health, Iran University of Medical Science, Tehran 1449614535, Iran.
Masumeh ShahsavnSchool of Public Health, Iran University of Medical Science, Tehran 1449614535, Iran.
Saeed KalantariDepartments of Infectious Diseases and Tropical Medicine, Iran University of Medical Sciences, Tehran 1449614535, Iran.
Razi Vaccine and Serum Research Institute · IRIran University of Medical Sciences · IRPasteur Institute of Iran · IRTarbiat Modares University · IRUniversity of Nottingham · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

immune responseimmunogenicityintranasal vaccinerecombinant vaccineSARS-CoV-2

Identifiers

PMID36851334
PMCPMC9961243
OpenAlexW4321107945

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.